Project Number 5R44AG067866-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator LIM, MARK Principal Investigator First Name MARK Principal Investigator Last Name LIM Awardee Organization AMBERGEN, INC Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,249,958 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official LUO, YUAN
